CUtLASS confirms CATIE.
Jim
J
Mintz
Alex
A
Kopelowicz
D014150:Antipsychotic Agents / Q000145:classification / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000145:classification / Q000627:therapeutic use; D006801:Humans; D000077152:Olanzapine; D010352:Patient Dropouts / Q000706:statistics & numerical data; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data*; D012559:Schizophrenia / Q000188:drug therapy*; D013469:Sulpiride / Q000145:classification / Q000627:therapeutic use; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D013469:Sulpiride; D000077152:Olanzapine